Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular components involved in macropinocytosis and vacuolization represent a group of molecular entities that regulate the large-scale internalization of extracellular fluid and the subsequent formation of cytoplasmic vacuoles. Macropinocytosis is a clathrin-independent endocytic process often exploited by cancer cells, particularly those with RAS mutations, to scavenge nutrients from the microenvironment (Commisso et al., 2013). When this process is hyperactivated or when endosomal trafficking is disrupted, it leads to the accumulation of large vacuoles, eventually resulting in a non-apoptotic cell death known as methuosis (Maltese & Overmeyer, 2014). Pharmacological agents like MOMPP and MIPP are known to induce this phenotype by interacting with these components, although the precise molecular identities of all involved proteins have not been fully characterized (Overmeyer et al., 2011). These components are of significant interest in oncology as they provide a mechanism to induce death in cells that are resistant to conventional apoptosis. Additionally, because macropinocytosis is a key entry route for certain viruses and bacteria, these components are also relevant in the context of infectious diseases (Mercer & Helenius, 2009). Targeting this pathway requires careful calibration to avoid systemic toxicity, as macropinocytosis also plays roles in normal physiological processes like immune surveillance by dendritic cells (Lim & Gleeson, 2011).
Induction of methuosis through hyperstimulation of macropinocytosis and inhibition of endosomal trafficking/recycling, or inhibition of macropinocytotic nutrient uptake.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular components involved in macropinocytosis and vacuolization.